Muscarinic acetylcholine receptor subtype, m2: Diverse functional implications of differential synaptic localization

Life Sciences

Volumn 60, Issue 13-14, 1997, Pages 1031-1038

  Rouse, Susan T ^a   Thomas, Traci M ^a   Levey, Allan I ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

hippocampus; m2 muscarinic acetylcholine receptor; presynaptic autoreceptor; presynaptic heteroreceptor; striatum

Indexed keywords

AUTORECEPTOR; MUSCARINIC M2 RECEPTOR; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; RECEPTOR ANTIBODY; RECEPTOR SUBTYPE;

ANIMAL TISSUE; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; NERVE ENDING; NONHUMAN; RAT; SEPTUM NUCLEUS; SYNAPSE; TISSUE DISTRIBUTION;

ANIMALS; AUTORECEPTORS; CORPUS STRIATUM; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; RECEPTORS, PRESYNAPTIC; SYNAPSES;

EID: 0030894832     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00044-1     Document Type: Conference Paper

References (60)

1. M.H. WEILER, Characterization of muscarinic receptors modulating acetylcholine release in the rat neostraitum, in Central Cholinergic Synoptic Transmission, M. Frotscher and U. Misgeld, (eds.), 204-211, Birkhäuser Verlag, Basel/Boston/Berlin (1989).
2. M. RAITERI, M. MARCHI, AND P. PAUDICE, Ann. New York Acad. Of Sci. 604 113-129 (1990).
3. U. MISGELD, M. WEILER, AND D. CHEONG, Brain Res. 253 317-320 (1982).
4. M. WEILER, U. MISGELD, AND D. CHEONG, Brain Res. 296 111-120 (1984).
5. J.T. COYLE, D.L. PRICE, AND M.R. DELONG, Science. 219 1184-1190 (1983).
6. M. MCKINNEY AND J.T. COYLE, Mayo Clin.Proc. 66 1225-1237 (1991).
7. K.D. DAVIS, et al., N.Eng.J.Med. 327 1253-1259 (1992).
8. D.C. MASH, D.D. FLYNN, AND L.T. POTTER, Science. 228 1115-1117 (1985).
9. M. MCKINNEY, J.H. MILLER, AND P.J. AAGAARD, J.Pharmacol.Exp.Ther. 264 74-78 (1993).
10. S. SUGITA, et al., Proc.Natl.Acad.Sci.(USA). 88 2608-2611 (1991).
11. M.H. RICHARDS, Br.J.Pharmacol. 99 753-761 (1990).
12. A. TOROSCIK AND E.S. VIZI, J.Neurosci.Res. 27 228-232 (1990).
13. M. MARCHI, et al., Brain Res. 520 347-350 (1990).
14. Z. PITTEL, et al., J.Neurochem. 55 665-672 (1990).
15. T. SUZUKI, et al., Neurosci.Lett. 84 209-212 (1988).
16. F. DORJE, et al., J.Pharmacol.Exp.Ther. 256 727-733 (1991).
17. M.T. VILARO, et al., Synapse. 11 171-183 (1992).
18. M.T. VILARO, et al., Neurosci. 47 367-393 (1992).
19. D.C. MASH AND L.T. POTTER, Neurosci. 19 551-564 (1986).
20. A.I. LEVEY, et al., J.Comp.Neurol. 351 339-356 (1995).
21. S.M. HERSCH, et al., J.Neurosci. 14 3351-3363 (1994).
22. L. MRZLJAK, A.I. LEVEY, AND P.S. GOLDMAN-RAKIC, Proc.Natl.Acad.Sci.(USA). 90 5194-5198 (1993).
23. M. GILMOR, et al., J. Neurosci. 16 2179-2190 (1996).
24. R. BURRY, D. VANDRE, AND D. HAYES, J. Hist. Cytochem. 40 1849-1856 (1992).
25. M. MARCHI, P. Sanguineti, and M. Raiteri, Neurosci.Lett. 116 347-351 (1990).
26. M. RAITERI, et al., J.Pharmacol.Exp.Ther. 254 496-501 (1990).
27. Z. YAN AND D.J. SURMEIER, J. Neurosci. 16 2592-2604 (1996).
28. M.-M. MESULAM, et al., J.Comp.Neurol. 214 170-197 (1983).
29. C.B. SAPER, J.Comp.Neurol. 222 313-342 (1984).
30. O.S. VINOGRADOVA, et al., Neurosci. 53 971-979 (1993).
31. C.H. VANDERWOLF, J.Comp.Physiol.Psychol. 88 300-332 (1975).
32. M. SEGAL, J.Physiol. 379 309-330 (1986).
33. K. PANG, M.J. WILLIAMS, AND D.S. OLTON, Brain Res. 632 150-160 (1993).
34. T.W. VICKROY, W.L. MALPHURS, AND N.C. DEFIEBRE, J. Pharmacol. Exp. Ther. 267 1198-1204 (1993).
35. M.J. STILLMAN, et al., Br. Res. Bull. 32 385-389 (1993).
36. R. POHORECKI, R. HEAD, AND E.F. DOMINO, J. Pharmacol. Exp. Ther. 244 213-217 (1988).
37. R.H. METCALF, et al., Neurosci.Lett. 93 85-90 (1988).
38. N.J. BUCKLEY, T.I. BONNER, AND M.R. BRANN, J.Neurosci. 8 4646-4652 (1988).
39. D.M. WEINER, A.I. LEVEY, AND M.R. BRANN, Proc.Natl.Acad.Sci.(USA). 87 7050-7054 (1990).
40. A.I. LEVEY, et al., J.Neurosci. 11 3218-3226 (1991).
41. A.I. LEVEY, et al., J.Neurosci. 15 4077-4092 (1995).
42. S.J. WALL, B.B. Wolfe, and L.F. Kromer, J.Neurochem. 62 1345-1351 (1994).
43. A. LEVEY, PNAS. in press (1996).
44. M. MARCHI, et al., Neurosci.Lett. 96 229-234 (1989).
45. M. MARCHI AND M. RAITERI, J.Pharmacol.Exp.Ther. 248 1255-1260 (1989).
46. M. RAITERI, et al., Eur. J. Pharmacol. 177 181-187 (1990).
47. K. KRNJEVIC, N. ROPERT, AND J. CASULLO, Brain Res. 438 182-192 (1988).
48. J. BEHRENDS AND G. BRUGGENCATE, J. Neurophys. 69 626-629 (1993).
49. N. HAJOS, et al., J. Neuroscience, submitted (1996).
50. S.T. ROUSE AND A.I. LEVEY, J. Comp. Neurol. submitted (1996).
51. J.V. NADLER, et al., Nature. 260 538-540 (1976).
52. E. SORIANO AND M. FROTSCHER, Hippocampus. 4 65-70 (1994).
53. A. HJORTH-SIMONSEN, J. Comp. Neurol. 146 219-232 (1972).
54. L. ZABORSKY, et al., J. Comp. Neurol. 250 282-295 (1986).
55. A.E. HALLANGER AND B.H. WAINER, J.Comp.Neurol. 274 483-515 (1988).
56. Y. LAMOUR, et al., Functional properties of septo-hippocampal neurons, in Brain Cholinergic Systems, M. Steriade and D. Biesold, (eds.), 265-281, Oxford University Press, New York (1990).
57. L.R. SUN AND J.B. SUSZKIW, Soc. Neurosci. Abst. 21 2038 (1995).
58. T. AKASU, H. HASUO, AND P. GALLAGHER, Soc. Neurosci. Abst. 21 2038 (1995).
59. P. DUTAR AND R.A. NICOLL, J.Neurosci. 8 4214-4224 (1988).
60. T.A. PITLER AND B.E. ALGER, J.Physiol. 450 127-142 (1992).